Compositions, devices, and methods related to prostate-specific membrane antigen
US8986655B2 · kind B2 · utility
12Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2010 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Mar 28, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E60/10
- WIPO fieldElectrical machinery, apparatus, energy
- WIPO sectorElectrical engineering
Abstract
PSMA ligands, compositions, and methods therefore are disclosed where the ligand is a peptide having the sequence X1X2CVEVX3QNSCX4X5 where X1-X5 are independently a natural or non-natural amino acid or a peptide having the sequence CALCEFLG [SEQ ID NO: 1]. Especially preferred aspects include diagnostic reagents for detection and/or quantification of PSMA in a sample, therapeutic reagents, and diagnostic imaging reagents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.